Handbook of Clinical Pancreatology

Posted Wednesday April 27, 2022

Now Available: GESA Handbook of Clinical Pancreatology Second Edition The Second Edition of the Handbook of Clinical Pancreatology, an educational resource from GESA, is now available from the Google Play Store and Apple Books. Further information is available on the GESA Clinical resources page. The Handbook of Clinical Pancreatology is an up to date, succinct guide rather than a definitive textbook. It is a resource you can refer to in the lecture hall, hospital ward or consulting room. The Handbook is an invaluable resource for medical students, doctors in training and experienced clinicians. 

What’s new: Each chapter is now co-authored by an Australian and international expert. I am honoured that pancreatology colleagues from around the globe (Scotland, England, France, Germany, India, Thailand, New Zealand, USA and Canada) agreed to contribute to the Handbook. This emphasises that the challenges of understanding the complexities of pancreatic physiology and thereby optimising the care of our patients enduring an array of pancreatic pathologies is shared by colleagues across the world. The necessity of a multidisciplinary approach to the treatment of our patients remains a consistent theme as reflected by the breadth of expertise amongst the authors. Three new chapters have been added to complete the scope of the Handbook; Paediatric Clinical Pancreatology, Cystic Fibrosis and the Pancreas and Diabetes of the Exocrine Pancreas. 


Related Articles

2025 Advanced Gastroenterology Training Opportunities (Match 2024) Information

Tuesday April 2, 2024

NZSG will be accepting applications for placements from the 8th of April 2024. The final date for applying is Friday the...

Vacancies Events + 2 More

Read more »

NZCCRTGE - Conjoint Committee News

Friday March 15, 2024

The NZCCRTGE has made a few changes we'd like to let you know about


Read more »

Supply Issue Notice from Pharmac

Thursday February 15, 2024

We've received news about long-term supply issue affecting the Dipentum brand of olsalazine (250 mg capsules and 500 mg ...

News Pharma News

Read more »